Search for: "Mylan, Inc."
Results 201 - 220
of 673
Sort by Relevance
|
Sort by Date
14 Nov 2016, 9:16 am
Kraft Food Brands Group LLC, No 16-341 (Does the general and broad definition of “residence” found in 28 U.S.C. 1391(c) apply to the patent venue statute 1400(b)) Civil Procedure – Personal Jurisdiction: Mylan Pharmaceuticals, et al. v. [read post]
28 Oct 2016, 2:35 pm
Mylan N.V. recently “announced that its subsidiary, Mylan Inc., has agreed to the terms of a $465 million settlement with the U.S. [read post]
19 Oct 2016, 8:28 am
Department of Justice (DOJ) to reject the proposed $465 million settlement reached between the government and Mylan, Inc. after it was discovered the beleaguered corporation, responsible for increasing the price of the life-saving EpiPen to $600 per 2-pak in August of this The post DOJ Urged to Reject Mylan Settlement by Senator appeared first on Legal Reader. [read post]
18 Oct 2016, 8:23 pm
The petition of the day is: Mylan Pharmaceuticals Inc. v. [read post]
18 Oct 2016, 8:26 am
The following consumer protection actions made headlines this week: Mylan Reaches $465 Million Settlement Over Medicaid Classification On October 7, 2016, Mylan Inc. announced that it had agreed to pay $465 million to resolve a DOJ investigation into Mylan’s classification of EpiPen as a generic drug that resulted in Medicaid and Medicare receiving a significantly smaller rebate on every prescription since 2007. [read post]
13 Oct 2016, 6:50 am
Lee, No. 16-446 (Eligibility of new use of old manufacture – blackjack game) Personal Jurisdiction: Mylan Pharmaceuticals, et al. v. [read post]
11 Oct 2016, 12:22 pm
EpiPen maker Mylan, Inc. has been ripping off Medicare and Medicaid for years but is only now being held accountable for their unethical, unprofessional and deceitful practices; the company has agreed to pay the government $465 million for having overcharged both insurance providers by classifying their drug as “generic,” thus reducing their percentage of the The post Mylan to Pay $465 Million for Overcharging Medicaid appeared first on Legal Reader. [read post]
28 Sep 2016, 8:39 am
Amgen Inc., et al., No. 16-332 (effectively extending exclusivity to 12 1/2 years; complement to the Sandoz petition) Mylan Pharmaceuticals, et al. v. [read post]
15 Sep 2016, 4:00 am
Dispill Inc., 2013 FC 1043. [read post]
9 Sep 2016, 4:15 am
The IPRs, which were filed by American pharmaceutical developer Mylan Inc. [read post]
6 Sep 2016, 3:36 pm
Schneiderman comes as Mylan is part of the widening backlash against Mylan's in response to its sharp increase in the price of the EpiPen, treatments for life-threatening anaphylactic shock. [read post]
4 Sep 2016, 8:42 am
With the price increase of the live-saving EpiPen from $100 per two-pack to over $600 per two-pack last week (conveniently in August when most parents who have children with allergies are set to purchase their necessary supplies of the drug before school starts), the company responsible for the hike, Mylan Inc., is backing away fromThe post EpiPen Increase Based in Greed, Not Need appeared first on Legal Reader. [read post]
2 Sep 2016, 2:15 am
Mylan Pharmaceuticals, Inc., 817 F.3d 755 (Fed. [read post]
29 Aug 2016, 5:02 am
Just last week, Mylan Inc. decided it was a good idea to raise the price of the life-saving EpiPen, which is used to stop a person from going into anaphylactic shock after experiencing an allergic reaction. [read post]
28 Jun 2016, 6:41 am
MacroSolve, Inc., No. 15-1369 (district court’s too-high burden) Globus Medical, Inc. v. [read post]
3 Jun 2016, 6:40 am
Steuben Foods, Inc. [read post]
18 May 2016, 8:19 am
Pulse Electronics, Inc. [read post]
4 May 2016, 12:00 am
We previously reported that the Internal Revenue Service (the “IRS”) took an aggressive position in challenging the treatment of a license agreement as a sale of a capital asset in the Tax Court case Mylan Inc. [read post]
3 May 2016, 9:00 pm
& Mylan Inc., 78 F. [read post]
3 May 2016, 1:42 am
BriarTek IP, Inc. v. [read post]
